Clinical Trial Update: Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention [Phase 4]

View source ↗

Summary

Phase 4 trial comparing anti-arrhythmic drug therapy versus catheter ablation as the first-line strategy to prevent implantable cardioverter-defibrillator shock…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Arrhythmia
• Ventricular Tachycardia

Drugs mentioned

• Anti-arrhythmic therapy (various agents)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Ventricular Tachycardia, Ventricular Arrhythmia | Phase 4 | Status: TERMINATED